The global cell processing market is estimated to be valued at US$ 1.93 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the cell processing market are LLC Medical Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics, bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA, SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife, Welling Home Health.
Key opportunities in the market include growing funding for cell based research, increasing demand for regenerative therapies and growth of specialized cell banks. New technological advancements like microfluidics, 3D cell culture, improved cell separation techniques and automation are expanding the applications of cell processing.

Technological advancements like automated Cell Processing Market Size  systems, cell counters, microfluidic cell sorters etc. are improving efficiency, precision and reproducibility of cell processing procedures. These advancements are helping lower processing costs and reduce manual workload.

Market Drivers
The major market driver is the growing reliance on cell based therapies for various chronic and life threatening diseases. Cell therapies hold promise for conditions like cancer, cardiovascular diseases, diabetes, neurological disorders and many others currently lacking effective treatment options. Increased funding for stem cell research from public as well as private sources is also fueling demand for cell processing capabilities. Rising healthcare expenditures coupled with growing geriatric population susceptible to complex diseases is another key factor propelling the cell processing market growth.

Get more insights on Cell Processing Market